rxstat › Shortages › Norepinephrine
Norepinephrine shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Norepinephrine products are in shortage in Canada (1 of 5 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
In shortage since
May 2, 2022
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageNOREPINEPHRINE BITARTRATE INJECTION USP
1MG · SOLUTION · GENERIC MEDICAL PARTNERS INC
DIN 02485680 · since May 2, 2022, no end estimate · Disruption of the manufacture of the drug.
ResolvedNOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION
0.016MG · SOLUTION · BAXTER CORPORATION
DIN 02501430 · ended Jun 8, 2026 · Demand increase for the drug.
ResolvedNOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION
0.032MG · SOLUTION · BAXTER CORPORATION
DIN 02501449 · ended Aug 29, 2024 · Delay in shipping of the drug.
DiscontinuedLEVOPHED
1MG · SOLUTION · PFIZER CANADA ULC
DIN 02241981
ResolvedLEVOPHED
1MG · SOLUTION · PFIZER CANADA ULC
DIN 02241981 · ended Jan 3, 2023 · Delay in shipping of the drug.
ResolvedNOREPINEPHRINE BITARTRATE INJ 1MG/ML USP
1MG · LIQUID · SANDOZ CANADA INCORPORATED
DIN 00893285 · ended Oct 12, 2022 · Demand increase for the drug.
AvoidedLEVOPHED
1MG · SOLUTION · PFIZER CANADA INC
DIN 02241981 · ended Sep 19, 2018 · Disruption of the manufacture of the drug.
ResolvedLEVOPHED 1.0 MG/ML
1MG · SOLUTION · HOSPIRA HEALTHCARE CORPORATION
DIN 02241981 · ended Jun 6, 2018 · Other (Please describe in comments)
ResolvedNOREPINEPHRINE BITARTRATE INJ 1MG/ML USP
1MG · LIQUID · SANDOZ CANADA INCORPORATED
DIN 00893285 · ended Jan 16, 2018 · Demand increase for the drug.
ResolvedLEVOPHED 1.0 MG/ML
1MG · SOLUTION · HOSPIRA HEALTHCARE CORPORATION
DIN 02241981 · ended May 29, 2017 · Shortage of an active ingredient.
What's happening
Norepinephrine is currently affected by an active shortage report filed with Health Canada by GENERIC MEDICAL PARTNERS INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Norepinephrine is classified under “CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES” (ATC C01CA).
Recent changes
Common questions
When will Norepinephrine be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Norepinephrine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.